SCHEMBL14797191

SCHEMBL14797191

Cc1ccc(Oc2ncc3nc(-c4cc(C)c(OCC(=O)O)c(C)c4)oc3n2)cc1Cl

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 4/20 0.79
MCL1 Q07820 1/20 0.38
CETP P11597 2/20 0.36
PTPN1 P18031 1/20 0.36
KDM4E B2RXH2 2/20 0.35
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
PPARG P37231 2/20 0.35
PPARA Q07869 2/20 0.35
EGLN1 Q9GZT9 1/20 0.34
CHEK2 O96017 1/20 0.34
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
NCOA2 Q15596 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14797114 0.92 S1PR1 (0.78) S1PR1MCL1CETPPTPN1KDM4E
SCHEMBL14797334 0.91 S1PR1 (0.77) S1PR1MCL1CETPPTPN1KDM4E
SCHEMBL2222062 0.91 S1PR1 (0.82) S1PR1MCL1CETPPTPN1PPARG
SCHEMBL14797164 0.89 S1PR1 (0.73) S1PR1CETPPTPN1PPARGPPARA
SCHEMBL14797116 0.89 S1PR1 (0.76) S1PR1CETPPTPN1PPARGPPARA
SCHEMBL2223316 0.89 S1PR1 (0.75) S1PR1CETPPTPN1KDM4EPPARG
SCHEMBL2224170 0.88 S1PR1 (1.00) S1PR1CETPPPARGPPARALMNA
SCHEMBL14797145 0.88 S1PR1 (0.77) S1PR1PTPN1KDM4EPPARGPPARA
SCHEMBL14797336 0.88 S1PR1 (0.72) S1PR1MCL1CETPPTPN1PPARG
SCHEMBL2223368 0.88 S1PR1 (0.83) S1PR1CETPPTPN1KDM4EPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846692-B2 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING OXGR1, EDNRA, EDF1 S1PR1 129/4885MCL1 3433/4885CETP 3150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.